Technology
Live Price
Offline$0.2458
+9.34% today
1Y Change
-94.80%
Window
Jun 30, 2025 → Jun 22, 2026
Coverage: 69 bars · Jun 30, 2025 → Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CALLIDITAS THERAPEUTICS AB (CLTEF) is a Technology stock with a market cap of $11.24B and listed on OTC. The stock last traded around $0.25 and down 94.8% across the available one-year price window (Jun 30, 2025 → Jun 22, 2026). Baseline metrics include revenue growth of -97.6%, EPS growth of -891.3%, a dividend yield of 0.0%. What stands out right now is revenue -97.6%, EPS -891.3%, free cash flow 0.0% with operating margin -31.9% and ROIC -25.3%. Valuation already assumes a fairly strong business story at price/sales 9.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CLTEF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
CLTEF is 115.28 pts behind over the shared 1Y window.
CLTEF had 90.85 pts deeper max drawdown than SPY.
CLTEF beat SPY in 0 of 2 calendar years shown and trailed in 2.
CLTEF
-94.80%
Normalized return
SPY
+20.48%
S&P 500
Excess Return
-115.28 pts
Relative to SPY
CLTEF Max Drawdown
-99.99%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for CLTEF and SPY.
| Year | CLTEF | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -55.12% | +6.71% | -61.83 pts | SPY |
| 2025 | -94.08% | +11.19% | -105.27 pts | SPY |
Unable to load analyst forecasts.
Timed out loading forecasts for CLTEF
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.